relative to insurance coverage for biomarker testing.

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text 6 Compare versions History 32 Sponsors 1

Version comparison

6 versions

Compare with

Sign in to read the full text

The document summary and details above are public. The full text is available to signed-in accounts.

Create a free account Sign in

PASSAGE PROBABILITY

35.8% Uncertain

Why this number

Stage base Passed First Chamber — base rate 50%, measured from NH's completed sessions
Momentum +2 59/100 from the pace of recorded action
Time since last action -21 149 days quiet
Sponsor influence +5 100/100

A transparent scoring model over stage, momentum, recency, sponsorship and recorded votes — not a trained predictor. Treat it as a way to rank attention, not as a forecast.